Association between CKD-MBD and hip-bone microstructures in dialysis patients.

Area of Science:

• Nephrology
• Orthopedics
• Bone Metabolism

Background:

• Longitudinal changes in hip bone microstructures and strength in dialysis patients are not well understood.
• The impact of chronic kidney disease-mineral and bone disorder (CKD-MBD) biomarkers on these bone changes requires further investigation.

Purpose of the Study:

• To examine longitudinal changes in hip bone microstructures and estimated bone strength in dialysis patients.
• To investigate the associations between time-dependent CKD-MBD biomarkers and bone health metrics.

Main Methods:

• Retrospective study of 276 dialysis patients over up to 2.5 years.
• Utilized 3D-SHAPER software to assess cortical and trabecular bone compartments and bone strength indices.
• Employed multivariate mixed models to analyze associations between CKD-MBD biomarkers and bone metrics.

Main Results:

• Significant decreases observed in areal bone mineral density (aBMD), volumetric BMD (vBMD), cortical thickness, and cortical surface BMD (sBMD).
• Estimated bone strength indices including cross-sectional area (CSA), CSMI, SM, and buckling ratio also deteriorated.
• Elevated intact-parathyroid hormone (i-PTH) showed significant inverse correlations with multiple bone parameters and strength indices, while serum calcium and phosphate levels did not.

Conclusions:

• Elevated PTH levels, rather than low PTH, are associated with the deterioration of hip bone microstructures in dialysis patients.
• Effective management of PTH levels is critical for maintaining hip bone microstructure in patients undergoing dialysis.